Neomycin-BSA
Neomycin-BSA is a conjugate of Neomycin and BSA. By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells[1].
Product Specifications
UNSPSC
12352100
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Inflammation/Immunology
Smiles
[Neomycin-BSA]
References & Citations
[1]Liu Y, et al. Pharmacokinetics of neomycin sulfate after intravenous and oral administrations in swine. J Vet Pharmacol Ther. 2021 Sep;44 (5) :850-853.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1071267-01 0.02 mg (E-Coli)
Recombinant Yersinia pestis bv. Antiqua Membrane-bound lytic murein transglycosylase C (mltC)
Sign In for Pricing
View Details MBS1071267-02 0.02 mg (Yeast)
Recombinant Yersinia pestis bv. Antiqua Membrane-bound lytic murein transglycosylase C (mltC)
Sign In for Pricing
View Details MBS1071267-03 0.1 mg (E-Coli)
Recombinant Yersinia pestis bv. Antiqua Membrane-bound lytic murein transglycosylase C (mltC)
Sign In for Pricing
View Details